Apalutamide for High-Risk Localized Prostate Cancer Following Radical Prostatectomy (Apa-RP)
Authots: Neal Shore, Jason Hafron, Daniel Saltzstein, Gordon Brown, Laurence Belkoff, Pankaj Aggarwal, Jennifer Phillips, Amitabha Bhaumik, Tracy McGowan
Dr. Shore awarded the LUGPA Presidential Citation
Dr. Shore was awarded the prestigious LUGPA Presidential Citation in recognition of his lifetime achievements in establishing LUGPA’s Continuing Medical Education programs as a priority for the organization and ensuring that LUGPA’s programs remain on the cutting edge of clinical excellence. Presented on the third day of November, 2023.
The New England Journal of Medicine, 10/19/23
The New England Journal of Medicine, 10/19/23
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate
Stephen J. Freedland, M.D., Murilo de Almeida Luz, M.D., Ugo De Giorgi, M.D., Ph.D., Martin Gleave, M.D., Geoffrey T. Gotto, M.D., M.P.H., Christopher M. Pieczonka, M.D., Gabriel P. Haas, M.D., Choung-Soo Kim, M.D., Miguel Ramirez-Backhaus, M.D., Antti Rannikko, M.D., Ph.D., Jamal Tarazi, M.D., M.P.A., Swetha Sridharan, M.B., B.S., Jennifer Sugg, M.S., Yiyun Tang, Ph.D., Ronald F. Tutrone, Jr., M.D., Balaji Venugopal, M.B., B.S., M.D., Arnauld Villers, M.D., Ph.D., Henry H. Woo, M.B., B.S., D.Med.Sc., Fabian Zohren, M.D., Ph.D., and Neal D. Shore, M.D.
Influencing Best Practices for Genomic and Germline Testing in Urology – Abhishek Srivastava
Influencing Best Practices for Genomic and Germline Testing in Urology – Abhishek Srivastava
Dr. Shore named 2023 Slotkin Lecturer for Outstanding Lecture
Congratulations to Dr. Neal D. Shore for being awarded the NSAUA 2023 Slotkin Lecturer for the outstanding lecture entitled “Current Therapy of Advanced GU Malignancies and Incorporating Clinical Trials Into Your Practice” October 20-22, 2023.
Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial
Neal D. Shore, MD, FACS, co-author
Received 16 March 2023, Revised 7 June 2023, Accepted 12 July 2023, Available online 12 August 2023.
Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer
Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer
July 12, 2023
Neal Shore, MD, FACS; David Wise, MD, PhD; and Sarah Nielsen Young, MS, LCGC
To read entire article, please click this link
https://dailynews.ascopubs.org/do/understanding-underutilization-germline-genetic-testing-prostate-cancer
Our Affiliates
